MOCERTATUG REZETECAN

UNII:	7K6VKK6DP4
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	MOCERTATUG REZETECAN
GSRS Full Record:	7K6VKK6DP4 i

3042848-25-6
Immunoglobulin G1, anti-(human B7 homolog protein B7H4) (human-Mus musculus monoclonal GSK5730912 γ-chain), disulfide with human-Mus musculus monoclonal GSK5730912 κ-chain, dimer, reduced, 214′′,223,229,229′,232,232′-hexakis(thioether) with N-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[[(1R)-1-cyclopropyl-2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-2-oxoethoxy]methyl]glycinamide
Mocertatug Rezetecan
immunoglobulin G1-kappa, anti-[Homo sapiens VTCN1 (V-set domain containing T cell activation inhibitor 1, B7 family member H4, B7H4, B7-H4)], humanized monoclonal antibody; conjugated on an average of six cysteinyl residues to rezetecan, comprising a linker and a camptothecin derivative (exatecan)
mocertatug rezetecan [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MOCERTATUG REZETECAN

Synonyms and Mappings

Resources